mri

We are thrilled to announce the successful completion of the EU Horizon 2020 project ASPIRE!
Our collaborative efforts have led to the development of an innovative new prototype for one-click perfusion analysis of ASL images. You can find a demo version of ExploreASL in mTRIAL here

ASL (Arterial Spin Labeling) is a cutting-edge MR imaging technique for contrast agent free perfusion imaging of the brain. It holds immense promise in improving the diagnosis and treatment monitoring of Alzheimer’s Disease. Especially for older adults with cardiovascular risk factors, ASL could be a game-changer.

Thank you all for your hard work and dedication, Gold Standard Phantoms,
Hochschule Darmstadt, Amsterdam UMC and mediri GmbH

Tired of deploying image evaluation scripts on your local machine? ASL image evaluation for brain perfusion analysis can be as easy as this: click, click.
Watch this video to see how images are uploaded from your local network to the central mTRIAL server – pseudonymization on the fly and image categorizaton included.

Just imagine… evaluating brain perfusion on arterial spin labeling images was just one click away. Watch this video to see how we implemented Explore ASL in our mTRIAL platform to facilitate and standardize your next clinical study on neurodegenerative diseases.

Stay tuned to see how easy your data reaches mTRIAL.
Contact us for more information on ASL imaging and analysis.

We are extremely happy to have a third sponsor on board for our ASL Network Dinner 2024 in Singapore: Quantified Imaging.
A warm welcome to Professor Michael Chappell and Dr Tom Kirk who span out their company from the University of Nottingham in 2023.

To register for the event, please click here.

More info on the sponsors: mediri, Gold Standard Phantoms, Quantified Imaging

World Alzheimer’s Day is a global effort to raise awareness and challenge the stigma around Alzheimer’s disease and other dementia. Do you know the differences between Alzheimer’s and dementia?
Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Alzheimer’s is one of several potential reasons for this decline, among them Frontotemporal Dementia, Huntington’s Disease, Parkinsons’s, or Vascular Dementia. Functional brain imaging is a cornerstone for the differentiation between all these different types of dementia and can support patient management as well as the research for potential therapies.
Perfusion imaging with Arterial Spin Labeling MRI has the potential to differentiate between Alzheimer’s and FTD but lacks standardization. In the ASPIRE project we develop an easy-to-use ASL evaluation tool that helps physicians to compare the brain perfusion pattern of a patient to a healthy control group. For more information visit aspire-mri.eu and alz.org.

Have you ever thought about assessing cerebral perfusion non-invasively in your next clinical trial? If so, this recently published review paper will address the most important questions such as how to equalize data acquisition across sites, how to perform QC and process the data. 
Read more here: https://lnkd.in/gE3Z8BKT

The implementation of ASL MRI for disease specific clinical cases has taken another milestone. Early 2023, a position paper supported by the ISMRM Perfusion Study Group updated and expanded the ASL MRI consensus paper from 2015 and provides guidance on using ASL MRI for clinical scenarios such as acute ischemic stroke, brain tumors and neurodegenerative diseases. 

Click here to read: https://lnkd.in/dvd7BCCv

ASL perfusion MRI permits non-invasive quantification of cerebral blood flow. The 2015 consensus paper on recommended implementation of ASL MRI established general guidelines for more comparable data acquisition and reproducible research. Mediri is happy to be part of this exciting journey.
Read more here: https://lnkd.in/eFXeQmi2